Excitingly, our recent study also discovered the therapeutic effect of SIS3 on SARS-CoV-2 N-induced AKI by inhibiting Smad3-dependent p21-mediated cell death pathway 79. The gene discussed is SMAD3; the disease is acute kidney injury.